ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,665Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 262

$413K Total Retail Price of All Prescriptions

Rank: 47 out of 262

441 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 441 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 441 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,593 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 483 416 1 1
LEVOTHYROXINE SODIUM 480 436 2 2
FUROSEMIDE 456 446 3 4
LISINOPRIL 407 373 4 3
POTASSIUM CHLORIDE 360 327 5 10
AMLODIPINE BESYLATE 344 335 6 6
METOPROLOL TARTRATE 321 295 7 8
WARFARIN SODIUM 288 280 8 12
METOPROLOL SUCCINATE 221 186 9 11
SERTRALINE HCL 201 187 10 14
OMEPRAZOLE 179 179 11 5
LOSARTAN POTASSIUM 164 154 12 17
GABAPENTIN 163 133 13 19
HYDROCODONE-ACETAMINOPHEN 161 135 S3 14 15
TAMSULOSIN HCL 146 146 15 25
DONEPEZIL HCL 133 133 16 23
PANTOPRAZOLE SODIUM 117 114 17 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 90 18 24
LOSARTAN-HYDROCHLOROTHIAZIDE 115 107 18 43
RISPERIDONE 114 114 20 50
TRAMADOL HCL 113 85 21 18
METFORMIN HCL 102 77 22 9
NEXIUM 100 82 23 57
ALLOPURINOL 96 96 24 22
ZOLPIDEM TARTRATE 93 85 25 26
POLYETHYLENE GLYCOL 3350 91 75 26 42
FENTANYL 91 70 S2 26 40
CARBIDOPA-LEVODOPA 89 85 28 66
CIPROFLOXACIN HCL 86 82 29 55
HYDROCHLOROTHIAZIDE 85 85 30 7
DIGOXIN 80 80 31 28
DIOVAN 76 68 32 47
CARVEDILOL 69 68 33 31
ATENOLOL 68 57 34 16
FLUTICASONE PROPIONATE 65 60 35 48
AZITHROMYCIN 57 49 36 44
ADVAIR DISKUS 57 39 36 34
PREDNISONE 56 49 38 29
OXYBUTYNIN CHLORIDE 53 46 39 90
CLOPIDOGREL 52 50 40 38
GLIPIZIDE XL 52 45 40 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.